Source: Nephrol Dial Transplant. Unidades: FM, IQ
Subjects: NEFROPATIAS, PREBIÓTICOS, INSUFICIÊNCIA RENAL CRÔNICA, INFLAMAÇÃO
ABNT
ARMANI, Rachel G et al. Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial. Nephrol Dial Transplant, v. 37, n. 1, p. 85–91, 2022Tradução . . Disponível em: https://doi.org/10.1093/ndt/gfaa335. Acesso em: 11 set. 2024.APA
Armani, R. G., Carvalho, A. B., Ramos, C. I., Hong, V., Bortolotto, L. A., Cassiolato, J. L., et al. (2022). Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial. Nephrol Dial Transplant, 37( 1), 85–91. doi:10.1093/ndt/gfaa335NLM
Armani RG, Carvalho AB, Ramos CI, Hong V, Bortolotto LA, Cassiolato JL, Oliveira NF, Cieslarová Z, Lago CL do, Klassen A, Cuppari L, Raj DS, Canziani MEF. Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial [Internet]. Nephrol Dial Transplant. 2022 ; 37( 1): 85–91.[citado 2024 set. 11 ] Available from: https://doi.org/10.1093/ndt/gfaa335Vancouver
Armani RG, Carvalho AB, Ramos CI, Hong V, Bortolotto LA, Cassiolato JL, Oliveira NF, Cieslarová Z, Lago CL do, Klassen A, Cuppari L, Raj DS, Canziani MEF. Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial [Internet]. Nephrol Dial Transplant. 2022 ; 37( 1): 85–91.[citado 2024 set. 11 ] Available from: https://doi.org/10.1093/ndt/gfaa335